Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs104886003
rs104886003
0.710 GeneticVariation BEFREE We also found that an activating (E545K) Pik3ca mutation, unlike Pten inactivation or Pik3ca H1047R mutation, cannot cooperate with Arid1a loss to promote ovarian cancer development in the mouse. 26279473

2016

dbSNP: rs121913279
rs121913279
0.710 GeneticVariation BEFREE We also found that an activating (E545K) Pik3ca mutation, unlike Pten inactivation or Pik3ca H1047R mutation, cannot cooperate with Arid1a loss to promote ovarian cancer development in the mouse. 26279473

2016

dbSNP: rs2699887
rs2699887
0.010 GeneticVariation BEFREE Interaction between PIK3CA rs2699887 SNP and age, number of liveborn, tobacco, alcohol, a family history of ovarian cancer and other factors are associated with ovarian cancer risk. 31288947

2019

dbSNP: rs3976507
rs3976507
0.010 GeneticVariation BEFREE Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk. 31288947

2019

dbSNP: rs6443626
rs6443626
0.010 GeneticVariation BEFREE Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk. 31288947

2019

dbSNP: rs104886003
rs104886003
A 0.710 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012

dbSNP: rs104886003
rs104886003
A 0.710 GeneticVariation CLINVAR

dbSNP: rs104886003
rs104886003
A 0.710 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005

dbSNP: rs121913279
rs121913279
T 0.710 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005

dbSNP: rs121913279
rs121913279
T 0.710 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012

dbSNP: rs121913279
rs121913279
G 0.710 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012

dbSNP: rs121913279
rs121913279
G 0.710 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005

dbSNP: rs1057519925
rs1057519925
A 0.700 GeneticVariation CLINVAR

dbSNP: rs1057519941
rs1057519941
G 0.700 GeneticVariation CLINVAR

dbSNP: rs1064793732
rs1064793732
A 0.700 CausalMutation CLINVAR

dbSNP: rs121913272
rs121913272
C 0.700 CausalMutation CLINVAR

dbSNP: rs121913272
rs121913272
C 0.700 GeneticVariation CLINVAR

dbSNP: rs121913273
rs121913273
A 0.700 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005

dbSNP: rs121913273
rs121913273
A 0.700 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012

dbSNP: rs121913273
rs121913273
C 0.700 CausalMutation CLINVAR

dbSNP: rs121913274
rs121913274
C 0.700 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005

dbSNP: rs121913274
rs121913274
C 0.700 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012

dbSNP: rs121913281
rs121913281
T 0.700 CausalMutation CLINVAR

dbSNP: rs121913286
rs121913286
A 0.700 CausalMutation CLINVAR PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. 22271473

2012

dbSNP: rs121913286
rs121913286
A 0.700 CausalMutation CLINVAR Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. 15647370

2005